A powerful consortium of some of the world’s most recognized names in higher education, health care, real estate and life sciences is collaborating to create a center for advanced biological innovation and manufacturing.
The $50 million first-of-its-kind center, which will be set up as an independent nonprofit, will explore regenerative therapies in a cross-sector environment that aims to shorten the gap between research, biomanufacturing and clinical application.
Often, a funded biotech startup will cultivate an idea, but have to wait up to 18 months or longer to manufacture a product. The as-yet-unnamed center aims to cut the backlog and bottleneck by providing manufacturing space at “favorable pricing,” with “pharma-grade” GMP manufacturing cleanrooms, according to a press release. The center will also provide a platform for workforce development and training.
Harvard University, the Massachusetts Institute of Technology, Fujifilm Diosynth Biotechnologies, GE Healthcare Life Sciences, and Alexandria Real Estate Equities will comprise the center’s board of directors.Read Complete Article